Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.
Antimicrob Agents Chemother. 2012 Feb;56(2):916-20. doi: 10.1128/AAC.05665-11. Epub 2011 Dec 5.
Neisseria gonorrhoeae is a major public health problem globally, especially because the bacterium has developed resistance to most antimicrobials introduced for first-line treatment of gonorrhea. In the present study, 96 N. gonorrhoeae isolates with high-level resistance to penicillin from 121 clinical isolates in Thailand were examined to investigate changes related to their plasmid-mediated penicillin resistance and their molecular epidemiological relationships. A β-lactamase (TEM) gene variant, bla(TEM-135), that may be a precursor in the transitional stage of a traditional bla(TEM-1) gene into an extended-spectrum β-lactamase (ESBL), possibly causing high resistance to all extended-spectrum cephalosporins in N. gonorrhoeae, was identified. Clonal analysis using multilocus sequence typing (MLST) and N. gonorrhoeae multiantigen sequence typing (NG-MAST) revealed the existence of a sexual network among patients from Japan and Thailand. Molecular analysis of the bla(TEM-135) gene showed that the emergence of this allele might not be a rare genetic event and that the allele has evolved in different plasmid backgrounds, which results possibly indicate that it is selected due to antimicrobial pressure. The presence of the bla(TEM-135) allele in the penicillinase-producing N. gonorrhoeae population may call for monitoring for the possible emergence of ESBL-producing N. gonorrhoeae in the future. This study identified a bla(TEM) variant (bla(TEM-135)) that is a possible intermediate precursor for an ESBL, which warrants international awareness.
淋病奈瑟菌是全球主要的公共卫生问题,特别是因为该细菌对大多数用于治疗淋病的一线抗菌药物产生了耐药性。在本研究中,对来自泰国 121 例临床分离株中对青霉素高度耐药的 96 株淋病奈瑟菌进行了研究,以研究与它们的质粒介导的青霉素耐药性相关的变化及其分子流行病学关系。鉴定出一种β-内酰胺酶(TEM)基因变体 bla(TEM-135),它可能是 bla(TEM-1)基因向扩展谱β-内酰胺酶(ESBL)过渡阶段的前体,可能导致淋病奈瑟菌对所有扩展谱头孢菌素产生高度耐药。使用多位点序列分型(MLST)和淋病奈瑟菌多抗原序列分型(NG-MAST)进行克隆分析表明,来自日本和泰国的患者之间存在性网络。bla(TEM-135)基因的分子分析表明,该等位基因的出现可能不是一个罕见的遗传事件,并且该等位基因已经在不同的质粒背景下进化,这可能表明它是由于抗菌药物压力而被选择的。在产青霉素酶的淋病奈瑟菌群体中存在 bla(TEM-135)等位基因可能需要监测未来可能出现的产 ESBL 的淋病奈瑟菌。本研究鉴定出一种 bla(TEM)变体(bla(TEM-135)),它可能是 ESBL 的中间前体,值得国际关注。